research Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata October 2021 in “Dermatology Reports” Higher IL-17A levels indicate more severe alopecia areata.
research Serum Interleukin 17 in Patients with Pattern Hair Loss June 2023 in “Benha Journal of Applied Sciences” Targeting IL-17 could help treat pattern hair loss.
research Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata December 2024 in “Kufa Medical journal” Higher levels of IL-17A and IL-2 are linked to alopecia areata.
research Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study April 2023 in “The Egyptian Journal of Hospital Medicine” Higher Interleukin 17A levels may indicate more severe alopecia areata.
research Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity September 2025 in “Diseases” Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.